<DOC>
	<DOCNO>NCT01327105</DOCNO>
	<brief_summary>The Essure procedure , FDA approve since 2002 CE Mark approve since 2001 , first permanent birth control method perform comfort physician 's office without hormone , cut , burn risk associate general anesthesia tubal ligation . Soft , flexible insert place woman 's fallopian tube cervix without incision . Over next three month , body form natural barrier around micro-inserts prevent sperm reach egg . Three month Essure procedure , doctor performs Essure Confirmation Test . In United States , test call hysterosalpingogram evaluate location insert whether fallopian tube block . Outside United States , standard x-ray perform evaluate location insert . The purpose study evaluate whether transvaginal ultrasound effective method confirm micro-insert location .</brief_summary>
	<brief_title>Essure Transvaginal Ultrasound ( TVU ) Study</brief_title>
	<detailed_description>This study previously post Conceptus , Inc. ( US ) . After acquire Conceptus , Inc. , Bayer HealthCare AG ( Germany ) sponsor trial .</detailed_description>
	<criteria>Women 21 44 year age Women 90300 pound ( 40136 kilogram ) Women schedule undergo Essure microinsert placement procedure permanent birth control Women willing accept risk pregnancy occur rely Essure device prevention pregnancy Women believe two viable fallopian tube Women able willing provide write informed consent Women mental capacity understand Informed Consent , comply protocol requirement , provide reliable feedback regard device wear Women available study visit Women willing allow data share sponsor regulatory body Women contraindicate Essure procedure accord Essure Instructions Use ( IFU ) Women know proximal tubal occlusion either fallopian tube Women fallopian tube sterilization procedure Women unicornuate uterus Women know endometrial myometrial pathology likely prevent access fallopian tube ostia Women schedule undergo intrauterine procedure time Essure placement Women pregnant suspect pregnant Women delivery termination pregnancy within last six week Women active recent upper low pelvic infection Women contraindicate Essure microinsert placement accord Essure Instructions Use ( IFU ) Women know intolerance transvaginal imaging</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>